Disease/Infection News

RSS

Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine

In a recent study published in The Lancet Microbe journal, researchers described the effectiveness of a modular capsid virus-like coronavirus disease 2019 (COVID-19) vaccination.

22 Jan 2023

Senolytics could be a beneficial therapeutic for COVID neuropathology

Researchers assess the effectiveness of multiple senolytic interventions in removing senescent cells in aged human brain organoids.

22 Jan 2023

Borrowing from weather and climate science models can help us prepare for future pandemics

A new study determines how insights from the climate and weather research field can improve the forecasting of pandemics.

22 Jan 2023

First known epidemic of highly pathogenic avian influenza H5N1 in farmed mink

Highly pathogenic avian influenza (HPAI) A(H5N1) is a strain of the avian influenza virus that primarily affects birds, particularly poultry. HPAI A(H5N1) is a highly contagious and deadly virus that can cause severe illness and death in birds, including chickens, ducks, geese, and turkeys.

22 Jan 2023

Study sheds light on the mechanisms behind virulence of MRSA blood stream infections

Researchers at Mount Sinai, in collaboration with researchers at New York University, have published a study in Cell Host and Microbe that sheds light on the mechanisms behind the severity, or virulence, of methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections.

20 Jan 2023

People with hybrid immunity are the most protected against severe COVID-19 and reinfection

A University of Calgary research group - which includes several Bachelor of Health Sciences alumni joined forces with members of the World Health Organization to tackle a global health question.

20 Jan 2023

Analysis of seemingly recovered COVID-19 patients indicates that SARS-CoV-2 infection can persist significantly longer than suggested by PCR-negative tests

Scientists have described the infection dynamics and clinical features of PCR-negative patients who eventually died due to the worsening of COVID-19.

20 Jan 2023

Longitudinal assessment of immunoglobulin G antibody responses to messenger ribonucleic acid vaccination doses and breakthrough infections

Researchers evaluated immunoglobulin G (IgG) responses to coronavirus disease 2019 (COVID-19) messenger ribonucleic acid (mRNA) vaccinations.

20 Jan 2023

How effective are prior SARS-CoV-2 infections and hybrid immunity against Omicron breakthrough infections?

Researchers performed a systematic review and meta-regression study to determine the breadth and duration of the protective immunity conferred by previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and hybrid immunity.

20 Jan 2023

Study shows increase in medical encounters six months post-SARS-CoV-2 infection, with vaccination lowering persistent symptoms risk

Researchers identified factors related to PCC [post-COVID-19 (coronavirus disease 2019] symptoms and assessed changes in PCC medical visits.

20 Jan 2023

Comprehensive profiling of human-to-human oral and intestinal microbial transmission

Researchers identified widespread bacterial strain sharing among humans (>10 million sharing instances) with distinctive patterns of transmission including vertical transmission, transmission within households, and the population.

20 Jan 2023

A cut-off score can accurately identify individuals with high levels of fear about COVID-19

The coronavirus disease 2019 (COVID-19) pandemic has had profound effects, both globally and on a highly personal level. Now, researchers from Japan have developed an accurate way of assessing the effects of the pandemic on our emotional health and wellbeing.

20 Jan 2023

WHO reports a severe case of avian (bird) flu in Ecuador

In a recent article published in the Disease Outbreak News section of the World Health Organization (WHO) website, they reported severe infection from the current H5 clade of avian influenza A virus in a nine-year-old girl inhabiting a rural province of Bolívar in Ecuador.

20 Jan 2023

New trial evaluates Omicron BA.1–adapted BNT162b2 vaccine in older adults

Researchers reported the findings of the phase III trial evaluating the Omicron BA.1–adapted mono and bivalent BNT162b2 coronavirus disease 2019 (COVID-19) vaccine in 55-year-old adults. These individuals had already received three 30μg doses of the BNT162b2 vaccine.

20 Jan 2023

WHO to launch council to accelerate the development of TB vaccine

The World Health Organization announces the creation of the TB Vaccine Accelerator Council.

20 Jan 2023

Metastatic Melanoma: key protein identified that aids the spread of skin cancer

In this interview, News-Medical spoke to Dr. Jeremy Carlton and Professor Victoria Sanz-Moreno about their latest research into the spread of skin cancer.

20 Jan 2023

Wistar scientists receive $397,663 to explore the ability of natural killer cells to kill HIV-infected cells

amfAR, The Foundation for AIDS Research, has awarded Luis J. Montaner, D.V.M., D.Phil., in collaboration with Mohamed Abdel-Mohsen, Ph.D., a Target Grant for $397,663 over two years. Montaner, who leads The Wistar Institute's HIV Research Program, is studying the ability of a type of immune cell known as natural killer (NK) cells to kill HIV-infected cells.

19 Jan 2023

Disease/Infection News

Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine

Senolytics could be a beneficial therapeutic for COVID neuropathology

Borrowing from weather and climate science models can help us prepare for future pandemics

First known epidemic of highly pathogenic avian influenza H5N1 in farmed mink

Study sheds light on the mechanisms behind virulence of MRSA blood stream infections

People with hybrid immunity are the most protected against severe COVID-19 and reinfection

Analysis of seemingly recovered COVID-19 patients indicates that SARS-CoV-2 infection can persist significantly longer than suggested by PCR-negative tests

Longitudinal assessment of immunoglobulin G antibody responses to messenger ribonucleic acid vaccination doses and breakthrough infections

How effective are prior SARS-CoV-2 infections and hybrid immunity against Omicron breakthrough infections?

Study shows increase in medical encounters six months post-SARS-CoV-2 infection, with vaccination lowering persistent symptoms risk

Comprehensive profiling of human-to-human oral and intestinal microbial transmission

A cut-off score can accurately identify individuals with high levels of fear about COVID-19

WHO reports a severe case of avian (bird) flu in Ecuador

New trial evaluates Omicron BA.1–adapted BNT162b2 vaccine in older adults

WHO to launch council to accelerate the development of TB vaccine

Metastatic Melanoma: key protein identified that aids the spread of skin cancer

Wistar scientists receive $397,663 to explore the ability of natural killer cells to kill HIV-infected cells

State-of-the-art Biocontainment Unit opened at MedStar Washington Hospital Center

Novel prion strain causes chronic wasting disease in a Finland moose

Mpox has been silently circulating in non-mpox-endemic nations for 20 years, according to new study

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News